HealthEquity, Inc. (NASDAQ:HQY) Given Average Recommendation of “Buy” by Analysts

Shares of HealthEquity, Inc. (NASDAQ:HQY) have been assigned a consensus rating of “Buy” from the twelve research firms that are currently covering the firm, Marketbeat.com reports. Twelve investment analysts have rated the stock with a buy rating. The average 1-year price target among analysts that have issued a report on the stock in the last year is $101.67.

Several research analysts have commented on the company. Robert W. Baird boosted their target price on HealthEquity from $98.00 to $104.00 and gave the stock an “outperform” rating in a research note on Tuesday, June 4th. KeyCorp boosted their price target on shares of HealthEquity from $95.00 to $100.00 and gave the company an “overweight” rating in a research note on Wednesday, June 5th. Barrington Research restated an “outperform” rating and issued a $105.00 target price on shares of HealthEquity in a research note on Friday. JMP Securities boosted their price objective on HealthEquity from $101.00 to $105.00 and gave the company a “market outperform” rating in a research note on Tuesday, June 4th. Finally, Bank of America reaffirmed a “buy” rating and set a $105.00 price target on shares of HealthEquity in a research note on Wednesday, July 3rd.

Insider Activity

In other news, Vice Chairman Stephen Neeleman sold 2,080 shares of HealthEquity stock in a transaction on Friday, June 7th. The shares were sold at an average price of $85.01, for a total transaction of $176,820.80. Following the transaction, the insider now owns 90,515 shares in the company, valued at approximately $7,694,680.15. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In related news, Vice Chairman Stephen Neeleman sold 2,080 shares of the firm’s stock in a transaction on Friday, June 7th. The shares were sold at an average price of $85.01, for a total value of $176,820.80. Following the completion of the transaction, the insider now directly owns 90,515 shares of the company’s stock, valued at $7,694,680.15. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Frank Corvino sold 7,705 shares of the firm’s stock in a transaction dated Monday, July 8th. The stock was sold at an average price of $81.89, for a total transaction of $630,962.45. Following the completion of the sale, the director now directly owns 6,070 shares of the company’s stock, valued at approximately $497,072.30. The disclosure for this sale can be found here. Insiders have sold a total of 77,511 shares of company stock worth $6,314,446 over the last 90 days. 2.20% of the stock is currently owned by insiders.

Hedge Funds Weigh In On HealthEquity

A number of hedge funds and other institutional investors have recently modified their holdings of the business. Motley Fool Asset Management LLC boosted its position in HealthEquity by 3,001.0% in the first quarter. Motley Fool Asset Management LLC now owns 3,762,064 shares of the company’s stock valued at $307,097,000 after buying an additional 3,640,748 shares during the last quarter. Norges Bank acquired a new stake in shares of HealthEquity during the fourth quarter worth about $43,482,000. Vaughan Nelson Investment Management L.P. acquired a new stake in shares of HealthEquity in the 1st quarter valued at $49,443,000. Wasatch Advisors LP boosted its stake in HealthEquity by 8.3% in the first quarter. Wasatch Advisors LP now owns 7,409,080 shares of the company’s stock valued at $604,803,000 after acquiring an additional 569,249 shares in the last quarter. Finally, Mackenzie Financial Corp lifted its holdings in shares of HealthEquity by 16.0% in the 2nd quarter. Mackenzie Financial Corp now owns 2,364,521 shares of the company’s stock valued at $203,822,000 after buying an additional 325,906 shares during the period. 99.55% of the stock is currently owned by institutional investors.

HealthEquity Stock Performance

NASDAQ HQY opened at $79.56 on Monday. The company has a current ratio of 4.39, a quick ratio of 4.39 and a debt-to-equity ratio of 0.44. HealthEquity has a 1 year low of $61.81 and a 1 year high of $88.26. The firm’s fifty day moving average price is $77.47 and its two-hundred day moving average price is $79.72. The firm has a market capitalization of $6.92 billion, a P/E ratio of 86.48, a price-to-earnings-growth ratio of 1.34 and a beta of 0.57.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings data on Monday, June 3rd. The company reported $0.55 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.47 by $0.08. The firm had revenue of $287.60 million during the quarter, compared to the consensus estimate of $278.78 million. HealthEquity had a net margin of 7.71% and a return on equity of 7.77%. As a group, research analysts anticipate that HealthEquity will post 2.12 EPS for the current year.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.